Mark McClure

498 total citations
18 papers, 276 citations indexed

About

Mark McClure is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Genetics. According to data from OpenAlex, Mark McClure has authored 18 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 11 papers in Rheumatology and 4 papers in Genetics. Recurrent topics in Mark McClure's work include Vasculitis and related conditions (13 papers), Otitis Media and Relapsing Polychondritis (9 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Mark McClure is often cited by papers focused on Vasculitis and related conditions (13 papers), Otitis Media and Relapsing Polychondritis (9 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Mark McClure collaborates with scholars based in United Kingdom, Australia and Denmark. Mark McClure's co-authors include David Jayne, Seerapani Gopaluni, Rachel Jones, Rona Smith, Joanna Tieu, S. Houghton, Dinakantha Kumararatne, Ania Manson, James Wason and Damian Fogarty and has published in prestigious journals such as Nature Immunology, Kidney International and Frontiers in Immunology.

In The Last Decade

Mark McClure

17 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark McClure United Kingdom 9 187 114 110 70 55 18 276
Jos Austen Netherlands 6 148 0.8× 112 1.0× 71 0.6× 81 1.2× 42 0.8× 6 287
Rok Ješe Slovenia 9 243 1.3× 182 1.6× 64 0.6× 53 0.8× 39 0.7× 21 283
Lorraine O’Neill Ireland 9 223 1.2× 175 1.5× 70 0.6× 100 1.4× 31 0.6× 16 321
J. Henes Germany 8 152 0.8× 126 1.1× 56 0.5× 47 0.7× 17 0.3× 19 261
Nicolò Pipitone Italy 7 196 1.0× 191 1.7× 48 0.4× 69 1.0× 51 0.9× 10 308
Vesna Júrčić Slovenia 7 202 1.1× 130 1.1× 33 0.3× 39 0.6× 70 1.3× 28 265
RA Watts United Kingdom 8 314 1.7× 176 1.5× 60 0.5× 92 1.3× 86 1.6× 27 394
Michelle Trevisin Australia 8 315 1.7× 143 1.3× 90 0.8× 86 1.2× 96 1.7× 9 401
Lindsay Lally United States 9 185 1.0× 153 1.3× 90 0.8× 32 0.5× 17 0.3× 19 257
L. Magnani Italy 8 281 1.5× 247 2.2× 60 0.5× 79 1.1× 68 1.2× 26 406

Countries citing papers authored by Mark McClure

Since Specialization
Citations

This map shows the geographic impact of Mark McClure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark McClure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark McClure more than expected).

Fields of papers citing papers by Mark McClure

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark McClure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark McClure. The network helps show where Mark McClure may publish in the future.

Co-authorship network of co-authors of Mark McClure

This figure shows the co-authorship network connecting the top 25 collaborators of Mark McClure. A scholar is included among the top collaborators of Mark McClure based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark McClure. Mark McClure is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Richoz, Nathan, Zewen Kelvin Tuong, Georgina Bowyer, et al.. (2025). Temporal profiling of human lymphoid tissues reveals coordinated defense against viral challenge. Nature Immunology. 26(2). 215–229. 1 indexed citations
2.
McClure, Mark, Matthew Coates, Simon Bond, et al.. (2024). Study protocol for a randomised, phase II, double-blind, experimental medicine study of obinutuzumab versus rituximab in ANCA-associated vasculitis: ObiVas. BMJ Open. 14(7). e083277–e083277. 7 indexed citations
3.
McClure, Mark, Seerapani Gopaluni, James Wason, et al.. (2023). A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol. Trials. 24(1). 180–180. 11 indexed citations
4.
Madsen, Bo, Mark McClure, Hans Dieperink, et al.. (2023). Age- and time-dependent increases in incident anti-glomerular basement membrane disease: a nationwide cohort study. Clinical Kidney Journal. 17(1). sfad261–sfad261. 1 indexed citations
5.
Gopaluni, Seerapani, Rona Smith, Elizabeth Wallin, et al.. (2022). Alemtuzumab for refractory primary systemic vasculitis—a randomised controlled dose ranging clinical trial of efficacy and safety (ALEVIATE). Arthritis Research & Therapy. 24(1). 81–81. 14 indexed citations
6.
Tieu, Joanna, Rona Smith, Seerapani Gopaluni, et al.. (2021). Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease. Frontiers in Immunology. 12. 671503–671503. 63 indexed citations
7.
Szpirt, Wladimir, Nicholas Carlson, Mark McClure, et al.. (2020). Increasing incidence and improved survival in ANCA-associated vasculitis—a Danish nationwide study. Nephrology Dialysis Transplantation. 37(1). 63–71. 25 indexed citations
8.
McClure, Mark, Yajing Zhu, Rona Smith, et al.. (2020). Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models. Lara D. Veeken. 60(3). 1491–1501. 26 indexed citations
9.
10.
McClure, Mark, James Wason, Seerapani Gopaluni, et al.. (2019). Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis. JCR Journal of Clinical Rheumatology. 25(5). 217–223. 32 indexed citations
11.
McClure, Mark, Lucy Truman, Marcos Martinez Del Pero, et al.. (2019). 030. TOLERABILITY AND CELL YIELD FROM NASAL BIOPSIES OBTAINED IN THE OUTPATIENT SETTING. Lara D. Veeken. 58(Supplement_2). 1 indexed citations
12.
Gopaluni, Seerapani, Joanna Tieu, Mark McClure, Penelope Moyle, & David Jayne. (2019). 013. PERCUTANEOUS LYMPH NODE BIOPSY TO EXPLORE IMMUNE DYSREGULATION IN VASCULITIS: A PILOT PROJECT. Lara D. Veeken. 58(Supplement_2).
13.
McClure, Mark, Seerapani Gopaluni, James Wason, et al.. (2019). 322. A RANDOMISED, DOUBLE-BLIND, CONTROLLED, MECHANISTIC STUDY OF RITUXIMAB AND BELIMUMAB COMBINATION THERAPY IN PR3 ANCA-ASSOCIATED VASCULITIS (COMBIVAS): STUDY PROTOCOL. Lara D. Veeken. 58(Supplement_2). 8 indexed citations
14.
McClure, Mark, Seerapani Gopaluni, David Jayne, & Rachel Jones. (2018). Publisher Correction: B cell therapy in ANCA-associated vasculitis: current and emerging treatment options. Nature Reviews Rheumatology. 14(12). 741–741. 1 indexed citations
15.
McClure, Mark, Seerapani Gopaluni, David Jayne, & Rachel Jones. (2018). B cell therapy in ANCA-associated vasculitis: current and emerging treatment options. Nature Reviews Rheumatology. 14(10). 580–591. 61 indexed citations
16.
McClure, Mark, et al.. (2018). Autonomic Response Testing Compared With Immunoglobulin E Allergy Panel Test Results: Preliminary Report.. PubMed. 24(2). 10–11. 1 indexed citations
17.
McClure, Mark & Rachel Jones. (2018). Update on Lupus Nephritis for GPs. Lupus. 27(1_suppl). 11–14. 2 indexed citations
18.
Pruthi, Rishi, Mark McClure, Anna Casula, et al.. (2016). Long-term graft outcomes and patient survival are lower posttransplant in patients with a primary renal diagnosis of glomerulonephritis. Kidney International. 89(4). 918–926. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jos Austen Breakdown of academic impact, for papers by Rok Ješe Breakdown of academic impact, for papers by Lorraine O’Neill Breakdown of academic impact, for papers by J. Henes Breakdown of academic impact, for papers by Nicolò Pipitone Breakdown of academic impact, for papers by Vesna Júrčić Breakdown of academic impact, for papers by RA Watts Breakdown of academic impact, for papers by Michelle Trevisin Breakdown of academic impact, for papers by Lindsay Lally Breakdown of academic impact, for papers by L. Magnani
Rankless by CCL
2026